In this study, we demonstrated a new set of 2,6,9-trisubstituted purine derivatives with broad inhibitory activity on three leukaemia-related tyrosine kinases: Bcr-Abl, BTK and FLT-3-ITD. The gene discussed is BTK; the disease is leukemia.